CN104407155B - A kind of AFP, GP73, PIVKA-II combined detection kit - Google Patents
A kind of AFP, GP73, PIVKA-II combined detection kit Download PDFInfo
- Publication number
- CN104407155B CN104407155B CN201410736252.0A CN201410736252A CN104407155B CN 104407155 B CN104407155 B CN 104407155B CN 201410736252 A CN201410736252 A CN 201410736252A CN 104407155 B CN104407155 B CN 104407155B
- Authority
- CN
- China
- Prior art keywords
- antibody
- pivka
- afp
- test paper
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 73
- 101710123134 Ice-binding protein Proteins 0.000 title claims abstract description 72
- 101710082837 Ice-structuring protein Proteins 0.000 title claims abstract description 72
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 title claims abstract description 72
- 108010063628 acarboxyprothrombin Proteins 0.000 title claims abstract description 67
- 102100021184 Golgi membrane protein 1 Human genes 0.000 title abstract description 16
- 101001040742 Homo sapiens Golgi membrane protein 1 Proteins 0.000 title abstract description 15
- 238000012360 testing method Methods 0.000 claims abstract description 74
- 201000000839 Vitamin K Deficiency Bleeding Diseases 0.000 claims abstract description 56
- 206010047634 Vitamin K deficiency Diseases 0.000 claims abstract description 56
- 208000016794 vitamin K deficiency hemorrhagic disease Diseases 0.000 claims abstract description 56
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000010931 gold Substances 0.000 claims abstract description 37
- 229910052737 gold Inorganic materials 0.000 claims abstract description 37
- 230000006698 induction Effects 0.000 claims abstract description 28
- 239000000020 Nitrocellulose Substances 0.000 claims abstract description 25
- 229920001220 nitrocellulos Polymers 0.000 claims abstract description 25
- 230000000274 adsorptive effect Effects 0.000 claims abstract description 7
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims description 70
- 239000012530 fluid Substances 0.000 claims description 24
- 238000013016 damping Methods 0.000 claims description 21
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 20
- 239000000872 buffer Substances 0.000 claims description 20
- 239000007921 spray Substances 0.000 claims description 18
- 241001494479 Pecora Species 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 13
- 238000002203 pretreatment Methods 0.000 claims description 12
- 239000004005 microsphere Substances 0.000 claims description 9
- 229930091371 Fructose Natural products 0.000 claims description 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 8
- 239000005715 Fructose Substances 0.000 claims description 8
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 8
- 229940037003 alum Drugs 0.000 claims description 8
- 239000007853 buffer solution Substances 0.000 claims description 8
- 239000001177 diphosphate Substances 0.000 claims description 8
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 8
- 235000011180 diphosphates Nutrition 0.000 claims description 8
- 235000013905 glycine and its sodium salt Nutrition 0.000 claims description 8
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 claims description 8
- 235000019982 sodium hexametaphosphate Nutrition 0.000 claims description 8
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 8
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 8
- 239000004471 Glycine Substances 0.000 claims description 6
- -1 alum Chemical compound 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 4
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000005520 cutting process Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 12
- 238000005516 engineering process Methods 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 101800001271 Surface protein Proteins 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000004587 chromatography analysis Methods 0.000 abstract description 2
- 239000011806 microball Substances 0.000 abstract description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 18
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 13
- 201000007270 liver cancer Diseases 0.000 description 10
- 208000014018 liver neoplasm Diseases 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 9
- 101000860173 Myxococcus xanthus C-factor Proteins 0.000 description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 7
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011088 calibration curve Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 206010073069 Hepatic cancer Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 108010077544 Chromatin Proteins 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000003483 chromatin Anatomy 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108050005430 Golgi membrane protein 1 Proteins 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003150 biochemical marker Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410736252.0A CN104407155B (en) | 2014-12-05 | 2014-12-05 | A kind of AFP, GP73, PIVKA-II combined detection kit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410736252.0A CN104407155B (en) | 2014-12-05 | 2014-12-05 | A kind of AFP, GP73, PIVKA-II combined detection kit |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104407155A CN104407155A (en) | 2015-03-11 |
CN104407155B true CN104407155B (en) | 2016-01-13 |
Family
ID=52644801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410736252.0A Active CN104407155B (en) | 2014-12-05 | 2014-12-05 | A kind of AFP, GP73, PIVKA-II combined detection kit |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104407155B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107345969A (en) * | 2016-05-05 | 2017-11-14 | 中国医学科学院基础医学研究所 | Purposes of the serum markers comprising AFP, GP73 and CEACAM1 in diagnosing hepatic diseases |
CN109444422A (en) * | 2018-12-17 | 2019-03-08 | 福建省立医院 | A kind of detection card and its construction method and application based on UPT-LF quantitative determination blood-serum P IVKA-II |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893831B1 (en) * | 1999-12-14 | 2005-05-17 | Sanko Junyaku Co., Ltd. | Immunoassay of PIVKA-II |
CN101526534A (en) * | 2009-03-10 | 2009-09-09 | 沈鹤柏 | Fluorescence immune chromatography test paper and preparing method and application thereof |
CN102226779A (en) * | 2011-03-28 | 2011-10-26 | 中国人民解放军第三军医大学第三附属医院 | Electrochemical immunodetection method |
CN102854324A (en) * | 2012-08-17 | 2013-01-02 | 西北大学 | Method for rapid nondestructive detection of liver tumor marker and test paper strip adopted by the method |
CN102879559A (en) * | 2011-07-12 | 2013-01-16 | 上海执诚生物科技股份有限公司 | Real-time quantitative detection reagent and method of time-resolved fluorescence immune chromatography |
CN202757941U (en) * | 2012-08-15 | 2013-02-27 | 沈阳医学院 | Liver cancer early diagnosis biological reagent box based on nanometer quantum dot technique |
CN103364550A (en) * | 2013-07-16 | 2013-10-23 | 天津大学 | Method and device for rapidly and quantitatively detecting tumor marker with immunochromatography test strip marked by quantum dots |
CN103529207A (en) * | 2013-10-17 | 2014-01-22 | 天津中新科炬生物制药有限公司 | Combined device for rapidly and quantitatively detecting multiple tumor markers |
-
2014
- 2014-12-05 CN CN201410736252.0A patent/CN104407155B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6893831B1 (en) * | 1999-12-14 | 2005-05-17 | Sanko Junyaku Co., Ltd. | Immunoassay of PIVKA-II |
CN101526534A (en) * | 2009-03-10 | 2009-09-09 | 沈鹤柏 | Fluorescence immune chromatography test paper and preparing method and application thereof |
CN102226779A (en) * | 2011-03-28 | 2011-10-26 | 中国人民解放军第三军医大学第三附属医院 | Electrochemical immunodetection method |
CN102879559A (en) * | 2011-07-12 | 2013-01-16 | 上海执诚生物科技股份有限公司 | Real-time quantitative detection reagent and method of time-resolved fluorescence immune chromatography |
CN202757941U (en) * | 2012-08-15 | 2013-02-27 | 沈阳医学院 | Liver cancer early diagnosis biological reagent box based on nanometer quantum dot technique |
CN102854324A (en) * | 2012-08-17 | 2013-01-02 | 西北大学 | Method for rapid nondestructive detection of liver tumor marker and test paper strip adopted by the method |
CN103364550A (en) * | 2013-07-16 | 2013-10-23 | 天津大学 | Method and device for rapidly and quantitatively detecting tumor marker with immunochromatography test strip marked by quantum dots |
CN103529207A (en) * | 2013-10-17 | 2014-01-22 | 天津中新科炬生物制药有限公司 | Combined device for rapidly and quantitatively detecting multiple tumor markers |
Non-Patent Citations (1)
Title |
---|
biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy;Kai Zhu等;《Biomarker Research》;20131231;第1卷(第10期);第1-3页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104407155A (en) | 2015-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104360085B (en) | A kind of AFP detection kit | |
Fan et al. | High-sensitive and multiplex biosensing assay of NSCLC-derived exosomes via different recognition sites based on SPRi array | |
Yu et al. | Disposable lateral flow-through strip for smartphone-camera to quantitatively detect alkaline phosphatase activity in milk | |
BRPI0411059A (en) | diagnostic test strips for detecting an analyte of interest in a liquid sample, for detecting anti-HIV antibody in a sample, and for immuno-diagnostic pregnancy test strips, and for detecting an antibody of interest in a liquid sample. liquid sample | |
Yang et al. | Integrated microfluidic paper-based system for determination of whole blood albumin | |
Corstjens et al. | Fingerstick test quantifying humoral and cellular biomarkers indicative for M. leprae infection | |
NO20001126L (en) | A non-invasive transdermal system for detecting analytes | |
CN105588944B (en) | Application of AGP1, SERPINA3 and CDH1 content detection system in screening active tuberculosis patients | |
CN104407155B (en) | A kind of AFP, GP73, PIVKA-II combined detection kit | |
CA2510377A1 (en) | Use of nicotinamide n-methyltransferase as a marker for colorectal cancer | |
Demirbakan et al. | A novel electrochemical immunosensor based on disposable ITO-PET electrodes for sensitive detection of PAK 2 antigen | |
CN104391122B (en) | A kind of AFP, PIVKA-II combined detection kit | |
Ruivo et al. | Colorimetric detection of D-dimer in a paper-based immunodetection device | |
CN104459138B (en) | A kind of IGFBP-1 detection kit | |
JP2014531027A (en) | Electrochemical analysis | |
CN104360079B (en) | A kind of PIVKA-II detection kit | |
Martínez-Mancera et al. | Pre-clinical validation study of a miniaturized electrochemical immunoassay based on square wave voltammetry for early detection of carcinoembryonic antigen in human serum | |
Akutsu et al. | Immunohistochemical staining of skin-expressed proteins to identify exfoliated epidermal cells for forensic purposes | |
CN104360082B (en) | A kind of AFP, GP73 combined detection kit | |
CN104360080B (en) | A kind of golgiosome glycoprotein-73 detection kit | |
CN104459140B (en) | The detection kit of a kind of detection by quantitative Rheumatoid factors, polyclonal, antistreptolysin O, cyclic citrullinated peptid, c reactive protein | |
CN104459115B (en) | A kind of GP73, PIVKA-II combined detection kit | |
CN104360071B (en) | The kit of content of glycocholic acid in a kind of Fast Measurement serum or blood plasma | |
CN104374911B (en) | A kind of detection by quantitative rheumatoid factor, the detection kit of antistreptolysin O (ASO) | |
CN106442979A (en) | Fast quantitative immunity test strip used for detecting four indicators of hepatic fibrosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160307 Address after: 200436, room 238, No. three, 406 Shanghai Road, Zhabei District, China Patentee after: Shanghai Rui Rui Biotechnology Co., Ltd. Address before: Jiulongpo Branch Park four street 400039 Chongqing city 70-1, 70-2 block J No. six Patentee before: CHONGQING QIANDE BIOTECHNOLOGY CO., LTD. |
|
CB03 | Change of inventor or designer information |
Inventor after: Ji Quan Inventor after: Wang Lianghua Inventor before: Pan Nengke |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180102 Address after: 400000 Taikang Road Dadukou District of Chongqing Bridge Industrial Park C District No. 6 Building 30 layer 1-4 Patentee after: Chongqing Zhongyuan Ji Ji Biological Technology Co., Ltd. Address before: Room 406, No. 238, three road, Zhabei District River, sea Patentee before: Shanghai Rui Rui Biotechnology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: Floor 1-4, building 30, no.6, Taikang Road, Zone C, Jianqiao Industrial Park, Dadukou District, Chongqing 400000 Patentee after: Zhongyuan Huiji Biotechnology Co.,Ltd. Address before: Floor 1-4, building 30, no.6, Taikang Road, Zone C, Jianqiao Industrial Park, Dadukou District, Chongqing 400000 Patentee before: CHONGQING ZHONGYUAN HUIJI BIOTECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |